Signore, Michele http://orcid.org/0000-0002-0262-842X
Alfonsi, Romina http://orcid.org/0000-0001-5100-5491
Federici, Giulia
Nanni, Simona
Addario, Antonio
Bertuccini, Lucia
Aiello, Aurora http://orcid.org/0000-0002-8303-1528
Di Pace, Anna Laura
Sperduti, Isabella
Muto, Giovanni
Giacobbe, Alessandro
Collura, Devis
Brunetto, Lidia
Simone, Giuseppe
Costantini, Manuela
Crinò, Lucio
Rossi, Stefania
Tabolacci, Claudio
Diociaiuti, Marco
Merlino, Tania
Gallucci, Michele
Sentinelli, Steno
Papalia, Rocco
De Maria, Ruggero
Bonci, Désirée http://orcid.org/0000-0002-2472-5140
Article History
Received: 23 November 2020
Revised: 31 May 2021
Accepted: 7 June 2021
First Online: 21 June 2021
Ethics approval and consent to participate
: All patients’ samples were collected and handled in the study following the ethical internationally recognized guidelines and the project was approved by the Ethics Committees. Prospective training-like and advanced cancer pivotal cohorts were collected at San Giovanni Bosco and Humanitas, Turin hospitals and Regina Elena National Cancer Institute under the approval of Istituto Superiore di Sanità (CE-ISS 09-250, 2009; Prot. CE-ISS-PRE 17/18 of 11/01/2018; CE-IRE-350-13). Retrospective prostate and colon adenocarcinoma cases were collected at Regina Elena National Cancer Institute under the Italy-USA program and subjected to approval by Istituto Superiore di Sanità (Prot-PRE 202/06-ref-CE-ISS 06/140). NSCL-cancer were collected under Ethics Committees approval (Prot-ISS-PRE-416/17).
: The authors declare no competing interests.